Updated results from the phase II study of hyper-CVAD in combination with ofatumumab as frontline therapy for adults with CD20 positive (CD20+) acute lymphoblastic leukemia (ALL).

被引：0
|
作者：
Issa, Ghayas C.
Kantarjian, Hagop M.
Ravandi, Farhad
Thomas, Deborah A.
Khouri, Maria
Garcia-Manero, Guillermo
Garris, Rebecca S.
Cortes, Jorge E.
Short, Nicholas James
Sasaki, Koji
Schroeder, Heather M.
Kadia, Tapan M.
Verstovsek, Srdan
Daver, Naval Guastad
Jain, Nitin
Konopleva, Marina
O'Brien, Susan Mary
Jabbour, Elias
机构：
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 15期
关键词：
D O I：
10.1200/JCO.2016.34.15_suppl.7042
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7042
引用
收藏
页数：4
相关论文
共 50 条
  • [31] Phase II Study Of Combination Of Hyper-CVAD With Ponatinib In Front Line Therapy Of Patients (pts) With Philadelphia Chromosome (Ph) Positive Acute L phoblastic Leukemia (ALL)
    Jabbour, Elias
    Kantarjian, Hagop
    Thomas, Deborah A.
    Ravandi, Farhad
    Cortes, Jorge E.
    Faderl, Stefan H.
    Pemmaraju, Naveen
    Kadia, Tapan M.
    Garris, Rebecca
    Hillary, Prescott
    Garcia-Manero, Guillermo
    Borthakur, Gautam
    Wierda, William G.
    O'Brien, Susan
    BLOOD, 2013, 122 (21)
  • [32] Updated Results from a Phase II Study Hyper-CVAD, with or without Inotuzumab Ozogamicin, and Sequential Blinatumomab in Patients with Newly Diagnosed B-Cell Acute Lymphoblastic Leukemia
    Nguyen, Daniel
    Kantarjian, Hagop
    Short, Nicholas J.
    Jain, Nitin
    Haddad, Fadi G.
    Yilmaz, Musa
    Ferrajoli, Alessandra
    Kadia, Tapan M.
    Valero, Yesid Alvarado
    Maiti, Abhishek
    Zoghbi, Marianne
    Senapati, Jayastu
    Garris, Rebecca
    Zhao, Min
    Konopleva, Marina
    Ravandi, Farhad
    Jabbour, Elias
    BLOOD, 2024, 144 : 1439 - 1441
  • [33] Updated Results from a Phase II Study of Hyper-CVAD, with or without Inotuzumab Ozogamicin, and Sequential Blinatumomab in Patients with Newly Diagnosed B-Cell Acute Lymphoblastic Leukemia
    Nguyen, Daniel
    Kantarjian, Hagop M.
    Short, Nicholas J.
    Jain, Nitin
    Haddad, Fadi G.
    Yilmaz, Musa
    Ferrajoli, Alessandra
    Kadia, Tapan M.
    Valero, Yesid Alvarado
    Maiti, Abhishek
    Nasnas, Cedric
    Nasr, Lewis
    Garris, Rebecca
    Konopleva, Marina Y.
    Ravandi, Farhad
    Jabbour, Elias
    BLOOD, 2023, 142
  • [34] Hyper-CVAD and Sequential Blinatumomab in Adults with Newly Diagnosed Philadelphia Chromosome-Negative B-Cell Acute Lymphoblastic Leukemia: Results from a Phase II Study
    Short, Nicholas J.
    Kantarjian, Hagop M.
    Ravandi, Farhad
    Huang, Xuelin
    Ferrajoli, Alessandra
    Kadia, Tapan M.
    Thompson, Philip A.
    Alvarado, Yesid
    Jain, Nitin
    Yilmaz, Musa
    Khoury, Joseph D.
    Jorgensen, Jeffrey L.
    Wang, Sa A.
    Kornblau, Steven M.
    Konopleva, Marina
    Garcia-Manero, Guillermo
    Schroeder, Heather M.
    Kwari, Monica
    Paul, Shilpa
    Nwakanme, Benjamin
    Loiselle, Christopher
    Garris, Rebecca
    O'Brien, Susan M.
    Jabbour, Elias
    BLOOD, 2020, 136
  • [35] First report of phase 2 study of dasatinib with hyper-CVAD for the frontline treatment of patients with Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia
    Ravandi, Farhad
    O'Brien, Susan
    Thomas, Deborah
    Faderl, Stefan
    Jones, Dan
    Garris, Rebecca
    Dara, Samuel
    Jorgensen, Jeffrey
    Kebriaei, Partow
    Champlin, Richard
    Borthakur, Gautam
    Burger, Jan
    Ferrajoli, Alessandra
    Garcia-Manero, Guillermo
    Wierda, William
    Cortes, Jorge
    Kantarjian, Hagop
    BLOOD, 2010, 116 (12) : 2070 - 2077
  • [36] Phase II study of hyper-CVAD followed by nelarabine consolidation in newly diagnosed patients with T cell acute lymphoblastic leukemia/lymphoblastic lymphoma (ALL/LL).
    Vigil, C. E.
    Kantarjian, H.
    Thomas, D. A.
    O'Brien, S. M.
    Kashani, F. Ravandi
    Koller, C. A.
    Burger, J. A.
    Garris, R. S.
    Baccus, M. D.
    Faderl, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [37] Prognostic Impact of CD20 and CD25 Expression in Patients with Philadelphia-Positive (Ph+) Acute Lymphoblastic Leukemia (ALL)
    Santos, Fabio P. S.
    O'Brien, Susan
    Thomas, Deborah A.
    Cortes, Jorge
    Faderl, Stefan
    Jorgensen, Jeffrey L.
    Garris, Rebecca
    Koller, Charles
    Kebriaei, Partow
    Ferrajoli, Alessandra
    Kantarjian, Hagop
    Ravandi, Farhad
    BLOOD, 2009, 114 (22) : 408 - 409
  • [38] Phase II Study of Nelarabine with Hyper-CVAD in Patients with Previously Untreated T Cell Acute Lymphoblastic Leukemia (T-ALL) and Lymphoblastic Lymphoma (LL)
    Jain, Preetesh
    Kantarjian, Hagop M.
    Thomas, Deborah A.
    Ravandi, Farhad
    Kadia, Tapan M.
    Burger, Jan A.
    Borthakur, Gautam
    Cortes, Jorge E.
    Daver, Naval
    Jabbour, Elias J.
    Koller, Charles Asa
    Konopleva, Marina
    Pemmaraju, Naveen
    Kelly, Marry A.
    Garris, Rebecca
    O'Brien, Susan
    Faderl, Stefan
    BLOOD, 2012, 120 (21)
  • [39] Hyper-CVAD Plus Epratuzumab As Salvage Regimen for Younger Relapsed/Refractory CD22+B Acute Lymphoblastic Leukemia (ALL) Patients: Results of the Phase 2 Prospective Cheprall Study
    Chevallier, Patrice
    Chantepie, Sylvain
    Huguet, Franoise
    Raffoux, Emmanuel
    Thomas, Xavier
    Leguay, Thibaut
    Marchand, Tony
    Isnard, Francoise
    Charbonnier, Aude
    Maury, Sebastien
    Gallego-Hernanz, Maria-Pilar
    Robillard, Nelly
    Guillaume, Thierry
    Peterlin, Pierre
    Garnier, Alice
    Rialland, Fanny
    Le Houerou, Claire
    Goldenberg, David M.
    Wegener, William
    Bene, Marie C.
    Dombret, Herve
    BLOOD, 2016, 128 (22)
  • [40] A phase II study of hyper-CVAD with sequential blinatumomab (Blina), with or without inotuzumab ozogamicin (INO), in adults with newly diagnosed B-cell acute lymphoblastic leukemia (ALL).
    Short, Nicholas James
    Kantarjian, Hagop M.
    Ravandi, Farhad
    Yilmaz, Musa
    Kadia, Tapan M.
    Thompson, Philip A.
    Konopleva, Marina
    Ferrajoli, Alessandra
    Jain, Nitin
    Sasaki, Koji
    Valero, Yesid Alvarado
    Borthakur, Gautam
    Dinardo, Courtney Denton
    Ohanian, Maro
    Macaron, Walid
    Garris, Rebecca
    Zhao, Min
    Kwari, Monica
    Loiselle, Christopher
    Jabbour, Elias
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
12345